ATM and Huntington disease: Indeed, ATM reduction alleviates motor deficits caused by mutant HTT in drosophila and mouse models, and pharmacological inhibition of ATM by KU-60019 or KU-55933 also exerts neuroprotective effects in rat striatal neurons and HD patient iPSC-derived neurons (Lu et al., 2014).